Immunic (IMUX) Stock Forecast, Price Target & Predictions
IMUX Stock Forecast
Immunic stock forecast is as follows: an average price target of $5.00 (represents a 350.45% upside from IMUX’s last price of $1.11) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
IMUX Price Target
IMUX Analyst Ratings
Buy
Immunic Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 21, 2022 | Market Perform | Leerink Partners | $5.00 | $2.08 | 139.81% | 350.45% |
10
Immunic Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $1.11 | $1.11 | $1.11 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 16, 2024 | EF Hutton | - | Buy | Initialise |
Sep 04, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Aug 27, 2024 | B. Riley | - | Buy | Initialise |
Jul 16, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Apr 05, 2024 | Brookline Capital | - | Buy | Initialise |
Oct 21, 2022 | SVB Leerink | - | Market Perform | Downgrade |
Jun 10, 2022 | Roth Capital | Buy | Buy | Hold |
10
Immunic Financial Forecast
Immunic Revenue Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $470.77M | $452.66M | $452.66M | $434.56M | - | - | - | - | - | - | - | - | - | - | - | - | $6.00K | $6.00K | - |
High Forecast | $470.77M | $452.66M | $452.66M | $434.56M | - | - | - | - | - | - | - | - | - | - | - | - | $6.00K | $6.00K | - |
Low Forecast | $470.77M | $452.66M | $452.66M | $434.56M | - | - | - | - | - | - | - | - | - | - | - | - | $6.00K | $6.00K | - |
# Analysts | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 2 | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Immunic EBITDA Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 2 | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Immunic Net Income Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 2 | - |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $150.23M | $146.39M | $148.37M | $143.36M | $-9.48M | $-8.55M | $-7.95M | $-8.38M | $-16.55M | $-15.62M | $-15.33M | $-15.54M | $-18.22M | $-17.76M | $-17.43M | $-21.71M | $-23.63M | $-22.12M | $-23.55M |
High Forecast | $150.23M | $146.39M | $148.37M | $143.36M | $-9.48M | $-8.55M | $-7.95M | $-8.38M | $-16.55M | $-15.62M | $-15.33M | $-15.54M | $-18.22M | $-17.76M | $-17.43M | $-20.76M | $-21.66M | $-22.12M | $-23.55M |
Low Forecast | $150.23M | $146.39M | $148.37M | $143.36M | $-9.48M | $-8.55M | $-7.95M | $-8.38M | $-16.55M | $-15.62M | $-15.33M | $-15.54M | $-18.22M | $-17.76M | $-17.43M | $-24.54M | $-24.61M | $-22.12M | $-23.55M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Immunic SG&A Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 2 | - |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Immunic EPS Forecast
Quarter
Dec 28 | Sep 28 | Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | 4 | 2 | - |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $1.48 | $1.45 | $1.47 | $1.42 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.16 | $-0.15 | $-0.15 | $-0.15 | $-0.18 | $-0.18 | $-0.17 | $-0.21 | $-0.23 | $-0.22 | $-0.23 |
High Forecast | $1.48 | $1.45 | $1.47 | $1.42 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.16 | $-0.15 | $-0.15 | $-0.15 | $-0.18 | $-0.18 | $-0.17 | $-0.21 | $-0.21 | $-0.22 | $-0.23 |
Low Forecast | $1.48 | $1.45 | $1.47 | $1.42 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.16 | $-0.15 | $-0.15 | $-0.15 | $-0.18 | $-0.18 | $-0.17 | $-0.24 | $-0.24 | $-0.22 | $-0.23 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Immunic Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
STTK | Shattuck Labs | $1.01 | $12.00 | 1088.12% | Hold |
IMUX | Immunic | $1.11 | $5.00 | 350.45% | Buy |
CCCC | C4 Therapeutics | $4.01 | $13.50 | 236.66% | Buy |
ERAS | Erasca | $2.60 | $6.50 | 150.00% | Buy |
KZR | Kezar Life Sciences | $7.62 | $17.50 | 129.66% | Buy |
FHTX | Foghorn Therapeutics | $7.72 | $16.33 | 111.53% | Buy |
KRON | Kronos Bio | $0.87 | $1.63 | 87.36% | Buy |
NRIX | Nurix Therapeutics | $22.37 | $32.20 | 43.94% | Buy |
EWTX | Edgewise Therapeutics | $31.98 | $45.00 | 40.71% | Buy |
KYMR | Kymera Therapeutics | $43.51 | $51.50 | 18.36% | Buy |